49.: The fampridine upper limb study (FULS)

Modified-release 4-aminopyridine (fampridine) is licensed in Australia for the symptomatic treatment of walking disability in patients with multiple sclerosis (MS). Its potential for use in other neurological domains, its mode of action, and the reasons for widely variable responses in treated patie...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of clinical neuroscience 2014-11, Vol.21 (11), p.2048-2049
Hauptverfasser:	Simpson, Marion, Carey, Leeanne, Bardsley, Belinda, Yiannikas, Con, Macdonell, Richard
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!